These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 9812120

  • 1. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
    Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, Demitrack MA, Tollefson GD.
    Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
    [Abstract] [Full Text] [Related]

  • 2. Panic disorder: treatment with valproate.
    Woodman CL, Noyes R.
    J Clin Psychiatry; 1994 Apr; 55(4):134-6. PubMed ID: 8071256
    [Abstract] [Full Text] [Related]

  • 3. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.
    Depress Anxiety; 2007 Apr; 24(1):1-14. PubMed ID: 16894619
    [Abstract] [Full Text] [Related]

  • 4. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA, Schweizer E, Rickels K.
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [Abstract] [Full Text] [Related]

  • 5. Open prospective trial of fluoxetine for posttraumatic stress disorder.
    Nagy LM, Morgan CA, Southwick SM, Charney DS.
    J Clin Psychopharmacol; 1993 Apr; 13(2):107-13. PubMed ID: 8463442
    [Abstract] [Full Text] [Related]

  • 6. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E, Patterson W, Rickels K, Rosenthal M.
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [Abstract] [Full Text] [Related]

  • 7. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS, Fawcett J, Hertzman M, Papp LA, Jones W, Patterson WM, Swinson RP, Weise CC, Maddock RJ, Denahan AQ.
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [Abstract] [Full Text] [Related]

  • 8. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group.
    Michelson D, Pollack M, Lydiard RB, Tamura R, Tepner R, Tollefson G.
    Br J Psychiatry; 1999 Mar; 174():213-8. PubMed ID: 10448445
    [Abstract] [Full Text] [Related]

  • 9. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [Abstract] [Full Text] [Related]

  • 10. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.
    Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjödin I, Penttinen JT, Pedersen T, Lehto HJ.
    J Clin Psychiatry; 1998 Oct; 59(10):528-34. PubMed ID: 9818634
    [Abstract] [Full Text] [Related]

  • 11. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G, Rosenbaum JF.
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [Abstract] [Full Text] [Related]

  • 13. Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder.
    Nardi AE, Lopes FL, Valença AM, Freire RC, Nascimento I, Veras AB, Mezzasalma MA, de-Melo-Neto VL, Soares-Filho GL, King AL, Grivet LO, Rassi A, Versiani M.
    Psychiatry Res; 2010 Feb 28; 175(3):260-5. PubMed ID: 20036427
    [Abstract] [Full Text] [Related]

  • 14. Use of low-dose fluoxetine in major depression and panic disorder.
    Louie AK, Lewis TB, Lannon RA.
    J Clin Psychiatry; 1993 Nov 28; 54(11):435-8. PubMed ID: 8270588
    [Abstract] [Full Text] [Related]

  • 15. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR, Perel JM.
    Am J Psychiatry; 1995 May 28; 152(5):673-82. PubMed ID: 7726306
    [Abstract] [Full Text] [Related]

  • 16. Effect of fluvoxamine on panic disorder.
    Hoehn-Saric R, McLeod DR, Hipsley PA.
    J Clin Psychopharmacol; 1993 Oct 28; 13(5):321-6. PubMed ID: 8227490
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine efficacy in social phobia.
    Van Ameringen M, Mancini C, Streiner DL.
    J Clin Psychiatry; 1993 Jan 28; 54(1):27-32. PubMed ID: 8428894
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
    Greenblatt DJ, Harmatz JS, Shader RI.
    Arch Gen Psychiatry; 1993 Sep 28; 50(9):715-22. PubMed ID: 8357297
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.